Sirtex Medical agrees to $1.43bn acquisition by CDH and CGP

Australian medical device firm Sirtex Medical agreed to a binding scheme implementation deed for A$1.9bn ($1.43bn) acquisition proposal from CDH Genetech and China Grand Pharmaceutical and Healthcare (CGP). The deal is at A$33.6 per share, higher than a previous offer from Varian.

“Australian medical device firm Sirtex Medical has agreed to a binding scheme implementation deed for A$1.9bn ($1.43bn) acquisition proposal from Chinese company CDH Genetech and its strategic partner China Grand Pharmaceutical and Healthcare (CGP).”medicaldevice-network.com

• 1 source
• medicaldevice-network.comSirtex agrees to $1.4bn acquisition by China’s CDH - Medical Device NetworkDivya TirumalarajuJun 14, 2018

Summarized from public sources; check the original articles before acting on it.